Cancer prevalence set to treble

August 21, 2012, King's College London
Cancer prevalence set to treble

(Medical Xpress) -- The number of older people (aged 65 and over) living with cancer in the UK is set to more than treble by 2040 – from 1.3 million in 2010 to 4.1 million – according to a new study by King’s College London researchers.

The Macmillan-funded study, published in The British Journal of , shows nearly one in four (23 per cent) will have had a cancer diagnosis in 2040 – almost double the proportion in 2010 (13 per cent). This is nearly four times the proportion for people aged 45-64.

Lung cancer prevalence in older women will see the biggest increase. The prevalence of lung cancer in older women will more than double from in 2010 to 2040 (from 319 to 831 per 100, 000), whereas lung cancer prevalence in older men is expected to decrease. This is due to a dramatic decline in smoking among men in England since the 1970s.

The sharp rise in cancer prevalence is likely to be due to a number of reasons including the ageing population, increasing incidence and increasing cancer survival.

Professor Henrik Møller, one of the study authors at King’s, says: ‘The aim of this research is to provide long term projections of cancer prevalence in the UK. The research shows that large increases can be expected in the oldest age groups in the coming decades and with this an increased demand upon health services.’

Currently older face a multitude of barriers to getting the best care and . These include under treatment, a lack of practical support at home preventing them from going to hospital to get treatment and poor management of non-cancer related health problems.

Ciarán Devane, Chief Executive at Macmillan Cancer Support, said: ‘The care of older cancer patients is the ticking time bomb for society. These stark predictions should act as a warning to the NHS and social care providers of the problems ahead if older cancer patients are not offered the best treatment and support.

‘We have a moral duty to give people the best chance of beating cancer, regardless of their age. For cancer survival to improve, older people must be given the right treatment at the correct level of intensity, together with the practical support to enable them to take it up.

‘The barriers to older people getting treatment must be tackled. If we don’t get this right now many older people will be dying unnecessarily from cancer in the future.’

Macmillan is calling for a more effective way of assessing older people for treatment, more short-term practical support to enable them to take up recommended treatment and training for professionals working with older people within the NHS to promote age equality.

Macmillan, in partnership with Age UK and the Department of Health, has set up five pilots to test new models of older people’s care. They will report in December 2012.

Explore further: Age affects risk of being diagnosed with cancer at advanced stage

More information: Maddams J, Utley M and Møller H. 2012. 'Projections of cancer prevalence in the United Kingdom, 2010–2040'. British Journal of Cancer. www.nature.com/bjc/journal/vao … ull/bjc2012366a.html

Related Stories

Age affects risk of being diagnosed with cancer at advanced stage

March 2, 2012
Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.

Elderly breast cancer patients less likely to get surgery

June 17, 2011
(PhysOrg.com) -- University of Manchester researchers, working with colleagues in York, Leeds and Hull, looked at the records of more than 23,000 women with breast cancer diagnosed in the West Midlands, Yorkshire and North ...

Almost half of cancer survivors have ill health in later years

October 11, 2011
Forty-five per cent of cancer survivors in Northern Ireland suffer from physical and mental health problems years after their treatment has finished, according to new research from Macmillan Cancer Support and Queen's University ...

Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA

July 6, 2011
Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to research presented at the 14th World ...

Report estimates nearly 18 million cancer survivors in US by 2022

June 14, 2012
The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according to a first-ever report by the American Cancer Society in collaboration with the National ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.